Effectiveness of Varenicline: Testing Individual Differences

• Status: Completed
• Trial end date: 2016-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The study will evaluate the effectiveness of smoking cessation using Varenicline versus placebo. Effectiveness will be measured by the average number of cigarettes smoked per smoking day for up to 36 weeks.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Mind Research Network
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Riboflavin; Varenicline

Criteria

Inclusion Criteria:

• 18 yrs to 55 yrs

• smoker

Exclusion Criteria:

• Medical Contraindications